Penn Vet | Clinical Trial Detail - IMMUNE-MEDIATED HEMOLYTIC ANEMIA OR THROMBOCYTOPENIA : Evaluating the intestinal microbiome as a possible trigger for IMHA in dogs
Contact
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
610-444-5800
Directions
Ryan Hospital Philadelphia, PA
Emergencies:
215-746-8911
Appointments:
215-746-8387
Directions

IMMUNE-MEDIATED HEMOLYTIC ANEMIA OR THROMBOCYTOPENIA : Evaluating the intestinal microbiome as a possible trigger for IMHA in dogs

Nov 5, 2018

The purpose of this study is to investigate whether the bacterial population of the GI tract may be a contributing factor to the onset of immune-mediated hemolytic anemia or thrombocytopenia in dogs. We will ask to take a fecal sample from dogs at three time points over the course of eight weeks.

Eligibility:

  • Newly diagnosed idiopathic IMHA or ITP
  • Has received no treatment for IMHA or ITP
  • Has not received antibiotics within 5 days of diagnosis, or more than 3 days of antibiotics in the two weeks leading up to diagnosis
  • Has not received probiotics or prebiotics (including fiber supplements) within 5 days of diagnosis

    Benefits:

  • Owners will receive up to $500 for participation (given in installments, one after each sample collection)

 

For more information, please contact the VCIC at 215-573-0302 or vcic@vet.upenn.edu